Evidence map

ArticleFrontiers in pharmacology2024

Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation.

Guangzhuang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39687299